Watch Out for ‘Vitamin K’
Now that more of the widely abused anesthetic is in circulation for so-called 'recreational' purposes, new (and strange) consequences have begun to emerge.
Select Page
by C. Scott McMillin | Feb 27, 2025 | Addictive Substances | 0 |
Now that more of the widely abused anesthetic is in circulation for so-called 'recreational' purposes, new (and strange) consequences have begun to emerge.
by C. Scott McMillin | Feb 17, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | Jan 27, 2025 | Addictive Substances | 1 |
by C. Scott McMillin | Jan 13, 2025 | Addictive Substances | 0 |
by C. Scott McMillin | Nov 11, 2024 | Addictive Substances | 0 |
by C. Scott McMillin | Sep 2, 2024 | Public Policy | 0 |
by C. Scott McMillin | Aug 22, 2024 | Resources | 0 |
…how important it can be to legitimize a recognized drug of abuse as a medical treatment. That can pave the way for legal recreational use, which is often where the money is.
Read Moreby C. Scott McMillin | Aug 5, 2024 | Addictive Substances | 0 |
Before that, however, there were the amphetamines, introduced to America’s moms as aids to weight loss and a source of much-needed pep.
Read Moreby C. Scott McMillin | Jul 25, 2024 | Addictive Substances | 0 |
Psilocybin is of course a Schedule One controlled substance, while amanita is not. As a result, the amanita products are “…often marketed as a dietary supplement…”
Read Moreby C. Scott McMillin | Jul 18, 2024 | Addictive Substances | 0 |
Problem: even if society passes good laws to regulate sales, how can we enforce them?
Read Moreby C. Scott McMillin | May 13, 2024 | Addictive Substances | 0 |
The organization formed… as a public-benefit corporation, in anticipation that MDMA-assisted therapy would win FDA approval and start to reap taxable revenue that it couldn’t manage as a nonprofit.
Read Moreby C. Scott McMillin | Jan 25, 2024 | Addictive Substances | 0 |
Presumably, a licensed facilitator would be required to sign a code of ethical conduct, and would be subject to suspension or loss of license in the event they were found guilty of misbehavior.
Read Moreby C. Scott McMillin | Jan 11, 2024 | In the News | 0 |
“During our training, we were told numerous times that this is a safe, effective drug,” one of the two testified.
Read Moreby C. Scott McMillin | Dec 21, 2023 | Addictive Substances | 0 |
What seemed so incredibly important while under the influence had lost a lot of its charm when sober.
Read Moreby C. Scott McMillin | Nov 27, 2023 | Addictive Substances | 0 |
Translation: the absence of adequate masking would presumably explain why ketamine appeared superior – due to an error in the study design.
Read Moreby C. Scott McMillin | Nov 9, 2023 | Addictive Substances | 0 |
Once again based on experience, I’m confident that many of the folks who will try psilocybin in future, because of all the favorable publicity, will fall into those ‘excluded’ categories.
Read Moreby C. Scott McMillin | Sep 14, 2023 | Addictive Substances | 0 |
All that free positive publicity has surely been a great help to the emerging psychedelic industry and the elements in the financial community who are rushing to exploit it.
Read Moreby C. Scott McMillin | Jul 13, 2023 | Addictive Substances | 0 |
In 1961, two Harvard students ended up in the mental hospital after consuming psilocybin…” Not long afterwards, Harvard lost much of its enthusiasm for the (psilocybin research) program.
Read More